- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
The Radiologist's Role in Improving DBT Access Equity
Radiologists may not order a DBT exam for African American patients, but they can participate in improving access to the screening.
African American women have significantly less access to digital breast tomosynthesis (DBT) that do their white counterparts, according a study published recently in the Journal of the American College of Radiology.
Even though DBT improves cancer detection and reduces recall rates, researchers from PennMedicine found that, based on their study population of more than 385,000 women, only 44 percent of African American women undergo DBT. Among Asian and white women, the rates of 63 percent and 61 percent, respectively.
This inequity in access presents a significant problem because African American women are more likely to be diagnosed with more aggressive forms of breast cancer at younger ages. Having easier, more consistent access to could greatly improve their outcomes.
Although radiologists and mammographers do not order DBT exams for these women, they do have a role to play in improve access and reducing the inequity, said Linda Blount, MPH, president and chief executive officer for Black Women’s Health Imperative, a non-profit organization dedicated to improving health and wellbeing for African American women and girls.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
